Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

Starting soon · Not applicable

Conditions studied: Androgenic Alopecia, Hair Loss/Baldness, Hair Thinning

In brief

The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in men with androgenic alopecia. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 visits after voluntary consent has been given. Participants will be given a 90-day supply of the gummies at visits 1 and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

Key facts

Study ID

NCT07637071

Run by

Restore Biologics Holdings, Inc. dba Xtressé

People needed

40

Starts

2026-06-22

Expected to finish

2027-03-01

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males aged 18-65
• Norwood III to IV, vertex focused
• Fitzpatrick skin type I to VI
• Ability and willingness to comply with study protocol

You may not qualify if…

• Change in other hair treatments in 3 months prior to study enrollment.
• Known uncontrolled health conditions.
• History of hair or scalp disorders that could interfere with study results.
• History of metabolic syndrome.

Where it is running

• Advanced Dermatology & Cosmetic Surgery — Maitland, Florida, United States
• Advanced Dermatology & Cosmetic Surgery — Port Orange, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.